News
MaxCyte, Inc. - Research & Development Agreement with NIAID
RNS Number: 2054 H MaxCyte, Inc. 06 June 2017. MaxCyte and National Institute of Allergy and Infectious Diseases to. Maryland, USA- 06 June 2017- MaxCyte, Inc. today an nounces it has entered into a Cooperative Research and Development Agreement with the National Institutes of Health's National Institute of Allergy and Infectious Diseases to develop treatments...
RNS Number: 2054 H MaxCyte, Inc. 06 June 2017. MaxCyte and National Institute of Allergy and Infectious Diseases to. Maryland, USA- 06 June 2017- MaxCyte, Inc. today an nounces it has entered into a Cooperative Research and Development Agreement with the National Institutes of Health's National Institute of Allergy and Infectious Diseases to develop treatments...